天天舔天天爽_视频日韩_成人网线_天天草草草_免费一级在线观看_色综合色综合色综合色综合

美國 Celgene 新基醫藥 
Celgene的公司成立于1980年，其總部在美國新澤西洲Summit，現擁有2441名員工，從事治療癌癥和免疫炎癥等疾病以及研究、開發、推廣、銷售相關藥品和創新療法。它是一家全球性的生物制藥公司。
VIDAZA：VIDAZA用于治療骨髓增生異常綜合癥亞型；難治性貧血（ RA ）或難治性貧血伴環狀鐵（ RARS ），難治性貧血伴過剩（難治性貧血） ，難治性貧血伴過剩轉變（難治性貧血） ，慢性粒細胞白血病（ CMMoL ）。

THALOMID(thalidomide)醫藥：THALOMID(thalidomide)醫藥配合塞米松用于治療新診斷的多發性骨髓瘤。

REVLIMID? (lenalidomide)醫藥：REVLIMID? (lenalidomide)醫藥配合塞米松，用于治療患者的多發性骨髓瘤和輸血依賴性貧血。

Committed to Improving the Lives of Patients Worldwide
Celgene is a multinational biopharmaceutical company committed to improving the lives of patients worldwide.

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

There are numerous clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), glioblastoma, and ovarian, pancreatic and prostate cancer.

As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.

Our History
Explore Celgene's history - from our modest beginnings to our current position as a globally integrated and culturally diverse biopharmaceutical company.

Our People
Celgene employs more than 2,600 employees worldwide. Learn about the values that define our people.

World Map
Our commitment to patients extends around the world. Find a comprehensive listing of domestic and international Celgene offices.

Intellectual Property
Discover Celgene's deep and diverse intellectual property portfolio - a variety of novel scientific targets and approaches.

California Declaration of Compliance